Eradication therapy for early Pseudomonas aeruginosa infection in CF: Many questions still unanswered

Abstract

In summary, Pseudomonas aeruginosa remains the most common and significant pathogen for people with cystic fibrosis. The study by Taccetti et al. [6] emphasises that eradication regimens remain an important and cost-effective part of the armamentaria of the cystic fibrosis multidisciplinary team against this pathogen [6, 13], although the optimal antibiotic combination, dosages, modes of delivery and duration of therapy remains unresolved. Copyright©ERS Journals Ltd 2005.